1. Sandoval-Sierra, Jose Vladimir, Salgado García, Francisco I, Brooks, Jeffrey H, Derefinko, Karen J, Mozhui, Khyobeni. 2020. Effect of short-term prescription opioids on DNA methylation of the OPRM1 promoter. In Clinical epigenetics, 12, 76. doi:10.1186/s13148-020-00868-8. https://pubmed.ncbi.nlm.nih.gov/32493461/
2. Das, Akansha S, Sherry, Emily C, Vaughan, Robert M, Williams, Carol L, Prokop, Jeremy W. 2022. The complex, dynamic SpliceOme of the small GTPase transcripts altered by technique, sex, genetics, tissue specificity, and RNA base editing. In Frontiers in cell and developmental biology, 10, 1033695. doi:10.3389/fcell.2022.1033695. https://pubmed.ncbi.nlm.nih.gov/36467401/
3. Schmidt, Natalie, Windmann, Sonja, Reifenberger, Guido, Riemenschneider, Markus J. 2011. DNA hypermethylation and histone modifications downregulate the candidate tumor suppressor gene RRP22 on 22q12 in human gliomas. In Brain pathology (Zurich, Switzerland), 22, 17-25. doi:10.1111/j.1750-3639.2011.00507.x. https://pubmed.ncbi.nlm.nih.gov/21631628/
4. Elam, Candice, Hesson, Luke, Vos, Michele D, Latif, Farida, Clark, Geoffrey J. . RRP22 is a farnesylated, nucleolar, Ras-related protein with tumor suppressor potential. In Cancer research, 65, 3117-25. doi:. https://pubmed.ncbi.nlm.nih.gov/15833841/